Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas B Kitchen

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|May 14, 2019
Design, Synthesis, and Preclinical Efficacy of Novel Nonretinoid Antagonists of Retinol-Binding Protein 4 in the Mouse Model of Hepatic SteatosisChristopher L Cioffi, Boglarka Racz, Andras Varadi, et al.
Frontiers in Microbiology|October 7, 2015
Model-driven discovery of synergistic inhibitors against E. coli and S. enterica serovar Typhimurium targeting a novel synthetic lethal pair, aldA and prpCRamy K Aziz, Valerie L Khaw, Jonathan M Monk, et al.
Journal of Medicinal Chemistry|August 31, 2018
Design and Characterization of Novel Covalent Bromodomain and Extra-Terminal Domain (BET) Inhibitors Targeting a MethionineOlesya A Kharenko, Reena G Patel, S David Brown, et al.
Scientific Reports|November 5, 2015
Systems biology-guided identification of synthetic lethal gene pairs and its potential use to discover antibiotic combinationsRamy K Aziz, Jonathan M Monk, Robert M Lewis, et al.
Journal of Medicinal Chemistry|July 17, 2015
Bicyclic [3.3.0]-Octahydrocyclopenta[c]pyrrolo Antagonists of Retinol Binding Protein 4: Potential Treatment of Atrophic Age-Related Macular Degeneration and Stargardt DiseaseChristopher L Cioffi, Boglarka Racz, Emily E Freeman, et al.
Chemmedchem|February 2, 2019
Discovery of Small-Molecule Antibiotics against a Unique tRNA-Mediated Regulation of Transcription in Gram-Positive BacteriaKyla M Frohlich, Spencer F Weintraub, Janeen T Bell, et al.
Bioorganic & Medicinal Chemistry Letters|October 23, 2012
4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitorsAnthony D Pechulis, James P Beck, Matt A Curry, et al.
Journal of Medicinal Chemistry|September 12, 2014
Design, synthesis, and evaluation of nonretinoid retinol binding protein 4 antagonists for the potential treatment of atrophic age-related macular degeneration and Stargardt diseaseChristopher L Cioffi, Nicoleta Dobri, Emily E Freeman, et al.
Cell Reports. Medicine|October 25, 2024
A humanized monoclonal antibody targeting an ectonucleotidase rescues cardiac metabolism and heart function after myocardial infarctionShen Li, Bo Tao, Jijun Wan, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2015
Discovery of a new chemical series of BRD4(1) inhibitors using protein-ligand docking and structure-guided designBryan C Duffy, Shuang Liu, Gregory S Martin, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|May 14, 2019
Design, Synthesis, and Preclinical Efficacy of Novel Nonretinoid Antagonists of Retinol-Binding Protein 4 in the Mouse Model of Hepatic SteatosisChristopher L Cioffi, Boglarka Racz, Andras Varadi, et al.
Frontiers in Microbiology|October 7, 2015
Model-driven discovery of synergistic inhibitors against E. coli and S. enterica serovar Typhimurium targeting a novel synthetic lethal pair, aldA and prpCRamy K Aziz, Valerie L Khaw, Jonathan M Monk, et al.
Journal of Medicinal Chemistry|August 31, 2018
Design and Characterization of Novel Covalent Bromodomain and Extra-Terminal Domain (BET) Inhibitors Targeting a MethionineOlesya A Kharenko, Reena G Patel, S David Brown, et al.
Scientific Reports|November 5, 2015
Systems biology-guided identification of synthetic lethal gene pairs and its potential use to discover antibiotic combinationsRamy K Aziz, Jonathan M Monk, Robert M Lewis, et al.
Journal of Medicinal Chemistry|July 17, 2015
Bicyclic [3.3.0]-Octahydrocyclopenta[c]pyrrolo Antagonists of Retinol Binding Protein 4: Potential Treatment of Atrophic Age-Related Macular Degeneration and Stargardt DiseaseChristopher L Cioffi, Boglarka Racz, Emily E Freeman, et al.
Chemmedchem|February 2, 2019
Discovery of Small-Molecule Antibiotics against a Unique tRNA-Mediated Regulation of Transcription in Gram-Positive BacteriaKyla M Frohlich, Spencer F Weintraub, Janeen T Bell, et al.
Bioorganic & Medicinal Chemistry Letters|October 23, 2012
4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitorsAnthony D Pechulis, James P Beck, Matt A Curry, et al.
Journal of Medicinal Chemistry|September 12, 2014
Design, synthesis, and evaluation of nonretinoid retinol binding protein 4 antagonists for the potential treatment of atrophic age-related macular degeneration and Stargardt diseaseChristopher L Cioffi, Nicoleta Dobri, Emily E Freeman, et al.
Cell Reports. Medicine|October 25, 2024
A humanized monoclonal antibody targeting an ectonucleotidase rescues cardiac metabolism and heart function after myocardial infarctionShen Li, Bo Tao, Jijun Wan, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2015
Discovery of a new chemical series of BRD4(1) inhibitors using protein-ligand docking and structure-guided designBryan C Duffy, Shuang Liu, Gregory S Martin, et al.
Pageof 3